Is 17 Bottles of Codeine-Based Cough Syrup Commercial or Non-Commercial Under NDPS?

In India, possessing codeine-based cough syrup can raise serious legal questions, especially under the stringent Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. A common query arises: 17 Bottles Codine Base Cough Syrup is Commercial or Non Commercial? This question touches on critical distinctions between small, intermediate, and commercial quantities, which determine penalties and regulatory oversight.

This blog post breaks down the legal framework, judicial precedents, and quantitative analysis to clarify why 17 bottles typically fall into the non-commercial category—provided they meet specific thresholds. Note: This is general information based on laws and cases; consult a legal expert for advice tailored to your situation.

Understanding Key Definitions Under NDPS Act

The NDPS Act regulates narcotic drugs and psychotropic substances. Codeine, an opium derivative, is explicitly covered under Section 2(xvi)(c) as a phenanthrene alkaloid. However, not all codeine preparations are treated as narcotics.

Manufactured Drugs and Exceptions

• Section 2(xi) defines manufactured drug to include opium derivatives like codeine, unless exempted.
• Notification No. 826(E) dated 14.11.1985 (Entry 35) exempts preparations compounded with other ingredients containing not more than 100 mg codeine per dosage unit and not more than 2.5% concentration if established in therapeutic practice. Such cough syrups are not narcotic drugs under NDPS but fall under the Drugs and Cosmetics Act, 1940 (Schedule H).

  11111111111

Quantity Thresholds

• Small quantity: 10 grams of codeine.
• Commercial quantity: 1 kilogram of codeine.These apply to the pure active content, not the total mixture volume, but courts consider the entire preparation for classification if within limits.

  11111111111

Cough syrups with low codeine (e.g., 10 mg/5 ml or ~0.17-2.5%) are prescription drugs, not NDPS substances, when used medicinally.

Judicial Precedents on Codeine Cough Syrup

Indian courts have consistently ruled that low-concentration codeine syrups are not manufactured drugs under NDPS.

• In Iqbal Singh, the Supreme Court held that syrup with 0.17% codeine (below 2.5%) is not a manufactured drug, emphasizing the entire mixture and therapeutic use.

  11111111111

• Gavranjeet Singh @ Gavrana followed this, stating licensed possession for medicinal sale is regulated under Drugs and Cosmetics Act, not NDPS.
• Ashok Kumar and Full Bench decisions reinforced that Schedule H syrups within limits escape NDPS.

  22222222222

• Hira Singh clarified: Consider the mixture entirety; below-threshold codeine is non-narcotic.

  11111111111

These rulings protect legitimate medical stockists while targeting misuse.

Applying the Law to 17 Bottles

Assume standard 100 ml bottles with ~0.17% codeine phosphate (common in cases).

Quantitative Breakdown

• Total volume: 17 × 100 ml = 1,700 ml.
• Codeine per bottle: 0.17% of 100 ml ≈ 0.17 g (density ~1 g/ml).
• Total codeine: 17 × 0.17 g ≈ 2.89 grams.

This is well below the small quantity threshold of 10 grams. Thus:- Non-commercial under NDPS.- Not a manufactured drug due to exemption (low concentration, therapeutic).- Regulated under Drugs and Cosmetics Act if unlicensed or misused.

Possession by licensed sellers doesn't trigger NDPS rigors.

11111111111

Insights from Related Cases

Other High Court decisions echo this for similar quantities:

• In a Bombay High Court case, 20 bottles of 100 ml codeine syrup from a shop led to NDPS charges, but arguments focused on low content (~3.9 g max), akin to non-commercial.

  ASGAR ALI Vs The State

  MAHESH PRASAD Vs THE STATE OF BIHAR

  total 20 bottles, of capacity of 100 ml each, branded cough syrup Codine phosphate etc. were alleged to be present... upon calculation it can be maximum up to 3.9 gm of the Codine Phosphate may be present.

  MAHESH PRASAD Vs THE STATE OF BIHAR

• Chhattisgarh HC noted seizures like 160 bottles in vehicles, but smaller 20 bottles in another, highlighting scrutiny on quantity and context.

  GEDLAL THAKUR @ LALA THAKUR vs STATE OF CHHATTISGARH

• 90 bottles recovery from a medical shop was alleged, but defects in procedure noted, implying small quantities often don't escalate to commercial.

  CHANDAN KUMAR CHAUDHARY @ CHANDAN CHAUDHARY Vs The State

Larger hauls (e.g., 44,160 bottles) were deemed commercial, with courts denying bail under Section 37 NDPS due to scale. 2022 0 Supreme(Gau) 329

Court is of the view that... the contraband is a commercial quantity and the substance is chemically manufactured drug. 2022 0 Supreme(Gau) 329

In contrast, 85 bottles in a bail application showed courts weighing low pure content favorably. 2021 0 Supreme(Sikk) 3

A key Allahabad HC ruling on 61,000 bottles of Phensedyl (meeting Entry 35 exception) held it not narcotic, as it fulfilled compounding and concentration limits—NDPS inapplicable despite misuse suspicions. 2021 0 Supreme(All) 1129

Phensedyl New Cough Linctus is not a Narcotic Drug and any dealing in this drug would not be subject to provisions of the NDPS Act. 2021 0 Supreme(All) 1129

These cases illustrate: 17 bottles (low total codeine) align with non-commercial precedents.

Additional Regulatory Notes

• Licensing: Licensed stockists can possess for sale under Drugs and Cosmetics Act; unlicensed = violations there, not NDPS.
• Unlicensed/Non-Medicinal: May attract other laws, but NDPS only if thresholds exceeded.
• Transportation: GST invoices and NDPS Rule 67(4) proviso allow documented movement. 2022 0 Supreme(Gau) 329

Courts deny relief in massive commercial cases but grant bail/antipatory bail for small quantities. 2022 0 Supreme(Pat) 36

Key Takeaways

• 17 bottles (~2.89g codeine): Generally non-commercial, exempt from NDPS if within 2.5% and therapeutic.
• Regulated as Schedule H drugs.
• Always verify concentration, licensing, and intent.
• Misuse risks separate penalties.

This analysis aligns with notifications, Supreme Court, and High Court views. For specific cases, seek professional legal counsel—laws evolve, and facts matter.